https://immugeek.com/adaptive-....fraxel-multi-scale-e
Sarcoma-specific translocations or gene amplifications were verified in 110 out of 113 situations making use of FISH and/or RT-PCR as gold-standard. MDM2/CDK4 amplification and a complete of 25 distinct fusion genetics were identified in this cohort of patients utilising the NGS strategy. Overall, the sensitivity for the NGS panel is 97% with a specificity of 100 and 0% failure rate. Targeted NGS is apparently a feasible and cost-effective strategy to improve sar
Like
Comment
Share
